Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Obach

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 26, 2013
A perspective on the prediction of drug pharmacokinetics and disposition in drug research and developmentLi Di, Bo Feng, Theunis C Goosen, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 30, 2009
Liver tissue engineering in the evaluation of drug safetyAjit Dash, Walker Inman, Keith Hoffmaster, et al.
Chemical Research in Toxicology|September 1, 2009
A holistic strategy for characterizing the safety of metabolites through drug discovery and developmentDon Walker, Joe Brady, Deepak Dalvie, et al.
The Annals of Pharmacotherapy|December 22, 2005
Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolismRobert A Moller, Jeannine M Fisher, Ann E Taylor, et al.
Chemical Research in Toxicology|January 24, 2009
Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fractionJonathon N Bauman, Joan M Kelly, Sakambari Tripathy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humansAmin Kamel, R Scott Obach, Kevin Colizza, et al.
Journal of Medicinal Chemistry|May 19, 2009
Physicochemical determinants of human renal clearanceManthena V S Varma, Bo Feng, R Scott Obach, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 19, 2017
Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug RatioR Scott Obach, Jian Lin, Emi Kimoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 13, 2008
Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humansDeepak Dalvie, Weichao Chen, Chenghong Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
An improved method for cytochrome p450 reaction phenotyping using a sequential qualitative-then-quantitative approachAngela C Doran, Alyssa L Dantonio, Gabrielle M Gualtieri, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 26, 2013
A perspective on the prediction of drug pharmacokinetics and disposition in drug research and developmentLi Di, Bo Feng, Theunis C Goosen, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 30, 2009
Liver tissue engineering in the evaluation of drug safetyAjit Dash, Walker Inman, Keith Hoffmaster, et al.
Chemical Research in Toxicology|September 1, 2009
A holistic strategy for characterizing the safety of metabolites through drug discovery and developmentDon Walker, Joe Brady, Deepak Dalvie, et al.
The Annals of Pharmacotherapy|December 22, 2005
Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolismRobert A Moller, Jeannine M Fisher, Ann E Taylor, et al.
Chemical Research in Toxicology|January 24, 2009
Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fractionJonathon N Bauman, Joan M Kelly, Sakambari Tripathy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humansAmin Kamel, R Scott Obach, Kevin Colizza, et al.
Journal of Medicinal Chemistry|May 19, 2009
Physicochemical determinants of human renal clearanceManthena V S Varma, Bo Feng, R Scott Obach, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 19, 2017
Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug RatioR Scott Obach, Jian Lin, Emi Kimoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 13, 2008
Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humansDeepak Dalvie, Weichao Chen, Chenghong Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
An improved method for cytochrome p450 reaction phenotyping using a sequential qualitative-then-quantitative approachAngela C Doran, Alyssa L Dantonio, Gabrielle M Gualtieri, et al.
Pageof 20